Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
28,495,649
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
8,633,348
-
Shares change
-
+3,960,204
-
Total reported value, excl. options
-
$18,127,749
-
Value change
-
+$8,211,749
-
Number of buys
-
14
-
Number of sells
-
11
-
Price
-
$2.10
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q1 2018
As of 31 Mar 2018 Oncocyte Corporation - Common Shares, No Par Value (OCX) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,633,348 shares of stock of the company.
Largest 10 holders included BROADWOOD CAPITAL INC, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., BRIDGEWAY CAPITAL MANAGEMENT INC, NORTHERN TRUST CORP, Destination Wealth Management, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This table shows 27 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.